Breast cancer management: quality-of-life and cost considerations.
作者： Davide Radice , Alberto Redaelli
DOI: 10.2165/00019053-200321060-00003
关键词:
摘要: … diagnosed with breast cancer and 40 000 eventually died of … used in breast cancer trials, although their use is increasing. … breast cancer varies in different parts of the world. It is high in …
elsevier.com
springer.com
sci-hub.se 参考文章(50)
Per E. L??nning, Aromatase inhibitors and inactivators for breast cancer therapy. Drugs & Aging. ,vol. 19, pp. 277- 298 ,(2002) , 10.2165/00002512-200219040-00003
Malin M, Allen S, Age differences in the psychosocial problems encountered by breast cancer patients. Journal of The National Cancer Institute Monographs. pp. 191- ,(1994)
Priestman Tj, Quality of life after cytotoxic chemotherapy: discussion paper. Journal of the Royal Society of Medicine. ,vol. 77, pp. 492- 495 ,(1984)
Edlund B, Sneed Nv, Emotional responses to the diagnosis of cancer: age-related comparisons. Oncology Nursing Forum. ,vol. 16, pp. 691- ,(1989)
Niels Neymark, The Economic Burden of Cancer Springer, Berlin, Heidelberg. pp. 42- 53 ,(1998) , 10.1007/978-3-642-72123-6_5
A S Lichter, M E Lippman, D N Danforth, T d'Angelo, S M Steinberg, E deMoss, H D MacDonald, C M Reichert, M Merino, S M Swain, Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. Journal of Clinical Oncology. ,vol. 10, pp. 976- 983 ,(1992) , 10.1200/JCO.1992.10.6.976
A Coates, V Gebski, D Signorini, P Murray, D McNeil, M Byrne, J F Forbes, Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology. ,vol. 10, pp. 1833- 1838 ,(1992) , 10.1200/JCO.1992.10.12.1833
Bernard Fisher, Joseph Costantino, Carol Redmond, Roger Poisson, David Bowman, Jean Couture, Nikolay V Dimitrov, Norman Wolmark, D Lawrence Wickerham, Edwin R Fisher, Richard Margolese, Andre Robidoux, Henry Shibata, Jose Terz, AHG Paterson, Merrill I Feldman, William Farrar, James Evans, H Lavina Lickley, Mary Ketner, *, None, A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors New England Journal of Medicine. ,vol. 320, pp. 479- 484 ,(1989) , 10.1056/NEJM198902233200802
C. Hürny, , J. Bernhard, M. Castiglione-Gertsch, A.S. Coates, H.F. Peterson, R.D. Gelber, J.F. Forbes, C-M. Rudenstam, E. Simoncini, D. Crivellari, A. Goldhirsch, H-J. Senn, Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer The Lancet. ,vol. 347, pp. 1279- 1284 ,(1996) , 10.1016/S0140-6736(96)90936-8
B P Will, C Le Petit, J-M Berthelot, E M Tomiak, S Verma, W K Evans, Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs. British Journal of Cancer. ,vol. 79, pp. 1428- 1436 ,(1999) , 10.1038/SJ.BJC.6690228